NCT07081308 Brain-computer Interface With Plantar Pneumoorthoses for Post-stroke Rehabilitation
| NCT ID | NCT07081308 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Research Center of Neurology, Russia |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-10-05 |
| Primary Completion | 2026-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-10-05 with a primary completion date of 2026-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
STUDY PURPOSE The investigators are testing a new rehabilitation system that helps stroke patients recover their ability to walk and think more clearly. This system, called brain-computer interface with plantar pneumorthoses, uses brain signals to control a special device that provides gentle pressure to the feet, similar to what you feel when walking. The goal is to help patients regain walking skills, improve memory and thinking, and feel better emotionally. STUDY QUESTIONS The main questions the study aims to answer are: Whether the investigated technology can improve walking in post-stroke patients? Whether the training to control the technology can improve cognitive function in post-stroke patients? HOW THE STUDY WORKS The investigators compare two groups - one using the new system, another group receiving standard rehabilitation therapy. Up to 15 patients will try the new system: 10 sessions, each lasting 12 minutes (about 2 weeks, Monday-Friday). WHAT HAPPENS DURING TREATMENT? The equipment includes: Brain monitoring device: Safe infrared light sensors placed on the patient's head (like a cap) Computer software: Reads brain signals when the patient thinks about walking Foot device: Special pneumatic shoes that provide gentle pressure to the patient's feet Screen: Shows visual feedback during training. What the patient will do: Sit comfortably in a chair with special shoes on their feet, Complete the task: imagine walking or relax when instructed, What the patient will experience: They will see colors change on the screen and feel gentle pressure on their feet.
Eligibility Criteria
Inclusion Criteria: * Age 18-80 years * Primary or recurrent supratentorial ischemic stroke * Stroke onset 7 days to 24 months * Moderate to mild post-stroke lower limb motor impairments * Clinical stability * Voluntary participation and signing of informed consent Exclusion Criteria: * Severe cognitive impairments preventing instruction compliance * Sensory or severe motor aphasia * Severe visual impairments * Lower limb contractures * Inability to maintain sitting position
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07081308 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07081308 currently recruiting?
Yes, NCT07081308 is actively recruiting participants. Contact the research team at xarisovich@gmail.com for enrollment information.
Where is the NCT07081308 trial being conducted?
This trial is being conducted at Moscow, Russia.
Who is sponsoring the NCT07081308 clinical trial?
NCT07081308 is sponsored by Research Center of Neurology, Russia. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.